360iResearch Logo
Global Real World Evidence Solution Market
Report Code: MRR-9C0DA83 | Publishing Date: May 2020 | Number of Pages: 208
Global Real World Evidence Solution Market | Market Research Report | Cumulative Impact of COVID-19

Market Dynamics:

The factors attributing to the growth of the market are delays in drug development and the subsequent increase in development costs, drug safety and effectiveness after clinical trials, and shift from volume to value based care. However, some factors such as reluctance to rely on real-world studies may hinder the market growth. The Real World Evidence Solution Market is expected to showcase the opportunities such as emerging roles of wearable devices and ai in rwe and rising focus on end-to-end rwe services. In the near future market may face the possible challenges in the growth due to lack of universally accepted methodological standards and data processing infrastructure. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Real World Evidence Solution Market.

Market Segmentation & Coverage:

The research report categorizes the Real World Evidence Solution Market to forecast the revenues and analyze the trends in each of the following segments:

"The Services is projected to witness the highest growth during the forecast period"

On the basis of Component, the Real World Evidence Solution Market is studied across Data Set and Services. The Data Set further studied across Claims Data, Clinical Settings Data, Patient-Powered Data, and Pharmacy Data. The Data Set commanded the largest size in the Real World Evidence Solution Market in 2019, followed by the Services. On the other hand, the Services is expected to grow at the fastest CAGR during the forecast period, followed by the Data Set.

"The Immunology is projected to witness the highest growth during the forecast period"

On the basis of Therapeutic Area, the Real World Evidence Solution Market is studied across Cardiovascular, Immunology, Neurology, and Oncology. The Oncology commanded the largest size in the Real World Evidence Solution Market in 2019, followed by the Cardiovascular. On the other hand, the Immunology is expected to grow at the fastest CAGR during the forecast period, followed by the Neurology.

"The Clinical & Life Sciences Organization is projected to witness the highest growth during the forecast period"

On the basis of End-User, the Real World Evidence Solution Market is studied across Biopharmaceutical Company, Clinical & Life Sciences Organization, and Diagnostics or Medical Device Company. The Biopharmaceutical Company commanded the largest size in the Real World Evidence Solution Market in 2019, followed by the Clinical & Life Sciences Organization. On the other hand, the Clinical & Life Sciences Organization is expected to grow at the fastest CAGR during the forecast period, followed by the Diagnostics or Medical Device Company.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

On the basis of Geography, the Real World Evidence Solution Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Real World Evidence Solution Market in 2019, followed by the Europe, Middle East & Africa. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period, followed by the Europe, Middle East & Africa.

Company Usability Profiles:

The Real World Evidence Solution Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Real World Evidence Solution Market including Certara, L.P., Clinigen Group PLC, Cognizant Technology Solutions Corp., HealthiVibe, LLC, IBM Corporation, ICON PLC, IQVIA, Mercy Technology Services, Oracle Corporation, PAREXEL International Corporation, Pharmaceutical Product Development, LLC, SAS Institute, Inc., Sciformix Corporation, Syneos Health, and Turacoz.

Scope of the Report:

AttributeDetails
Base Year for Estimation2019
Historical Period2017 - 2018
Estimation Period2020 - 2021
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Real World Evidence Solution Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Real World Evidence Solution Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Real World Evidence Solution Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Real World Evidence Solution Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Real World Evidence Solution Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Real World Evidence Solution Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Real World Evidence Solution Market.
  • Evaluate the key vendors in the Real World Evidence Solution Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Research Process
      1. Define: Research Objective
      2. Determine: Research Design
      3. Prepare: Research Instrument
      4. Collect: Data Source
      5. Analyze: Data Interpretation
      6. Formulate: Data Verification
      7. Publish: Research Report
    2. Research Execution
      1. Initiation: Research Process
      2. Planning: Develop Research Plan
      3. Execution: Conduct Research
      4. Verification: Finding & Analysis
      5. Publication: Research Report
    3. Research Outcome
      1. 360iResearch™ Market Share Analysis
      2. 360iResearch™ Competitive Strategic Window
  3. Executive Summary
    1. Market Outlook
    2. Component Outlook
    3. Therapeutic Area Outlook
    4. End-User Outlook
    5. Geography Outlook
    6. Competitor Outlook
  4. Market Overview
    1. Introduction
    2. Real World Evidence Solution Market, By Component
    3. Real World Evidence Solution Market, By Therapeutic Area
    4. Real World Evidence Solution Market, By End-User
    5. Real World Evidence Solution Market, By Geography
  5. Market Dynamics
    1. Introduction
      1. Drivers
        1. Shift from volume to value based care
        2. Delays in drug development and the subsequent increase in development costs
        3. Drug safety and effectiveness after clinical trials
      2. Restraints
        1. Reluctance to rely on real-world studies
      3. Opportunities
        1. Rising focus on end-to-end RWE services
        2. Emerging roles of wearable devices and AI in RWE
      4. Challenges
        1. Lack of universally accepted methodological standards and data processing infrastructure
  6. Market Insights
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
  7. Global Real World Evidence Solution Market, By Component
    1. Data Set
      1. Claims Data
      2. Clinical Settings Data
      3. Patient-Powered Data
      4. Pharmacy Data
    2. Services
  8. Global Real World Evidence Solution Market, By Therapeutic Area
    1. Cardiovascular
    2. Immunology
    3. Neurology
    4. Oncology
  9. Global Real World Evidence Solution Market, By End-User
    1. Biopharmaceutical Company
    2. Clinical & Life Sciences Organization
    3. Diagnostics or Medical Device Company
  10. Americas Real World Evidence Solution Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  11. Asia-Pacific Real World Evidence Solution Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  12. Europe, Middle East & Africa Real World Evidence Solution Market
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  13. Competitive Landscape
    1. FPNV Positioning Matrix
      1. Quadrants
      2. Business Strategy
        1. Business Growth
        2. Industry Coverage
        3. Financial Viability
        4. Channel Support
      3. Product Satisfaction
        1. Value for Money
        2. Ease of Use
        3. Product Features
        4. Customer Support
    2. Market Ranking Analysis
    3. Market Share Analysis
    4. Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
  14. Company Usability Profiles
    1. Certara, L.P.
    2. Clinigen Group PLC
    3. Cognizant Technology Solutions Corp.
    4. HealthiVibe, LLC
    5. IBM Corporation
    6. ICON PLC
    7. IQVIA
    8. Mercy Technology Services
    9. Oracle Corporation
    10. PAREXEL International Corporation
    11. Pharmaceutical Product Development, LLC
    12. SAS Institute, Inc.
    13. Sciformix Corporation
    14. Syneos Health
    15. Turacoz
  15. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: SEGMENTATION & COVERAGE
  2. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  3. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  4. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  5. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  6. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  7. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  11. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  12. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  14. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  15. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  16. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  17. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  19. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  20. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  21. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  22. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  23. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  24. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  25. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  26. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  27. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  28. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  29. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  30. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  31. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  32. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  33. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  34. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  35. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  36. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  37. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  38. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  39. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  40. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  41. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  42. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  43. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  44. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  45. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  46. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  47. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  48. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  49. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  50. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  51. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  52. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  53. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  54. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  55. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  56. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  57. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  58. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  59. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  60. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  61. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  62. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  63. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  64. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  65. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  66. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  67. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  68. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  69. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  70. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  71. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  72. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  73. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  74. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  75. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  76. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  77. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  78. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  79. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  80. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  81. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  82. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  83. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  84. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  85. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  86. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  87. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  88. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  89. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  90. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  91. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  92. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  93. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  94. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  95. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  96. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  97. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  98. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  99. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  100. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  101. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  102. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  103. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  104. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  105. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  106. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  107. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  108. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  109. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  110. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  111. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  112. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  113. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  114. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  115. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  116. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  117. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  118. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  119. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  120. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  121. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  122. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  123. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  124. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  125. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  126. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  127. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  128. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  129. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  130. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  131. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  132. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
  133. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  134. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
  135. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: BUSINESS STRATEGY
  136. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: PRODUCT SATISFACTION
  137. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: RANKING
  138. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: MERGER & ACQUISITION
  139. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: AGREEMENT, COLLABORATION & PARTNERSHIP
  140. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  141. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: INVESTMENT & FUNDING
  142. null
  143. null
  144. null
  145. null
  146. null
  147. null
  148. null
  149. null
  150. null
  151. null
  152. null
  153. null
  154. null
  155. null
  156. null
  157. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: EDITION DETAILS
  158. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: LICENSE DETAILS
  159. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2019 VS 2025 (USD MILLION)
  2. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2019 VS 2025 (USD MILLION)
  3. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (USD MILLION)
  4. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2019 VS 2025 (USD MILLION)
  5. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  6. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET, BY TYPE
  7. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  8. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2025 (USD MILLION)
  9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2025 (USD MILLION)
  10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2025 (USD MILLION)
  11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  12. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: MARKET DYNAMICS
  13. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: PORTERS FIVE FORCES ANALYSIS
  14. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  15. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  16. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  17. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  18. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  19. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  20. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  21. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  22. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  23. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  24. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  25. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  26. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  27. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  28. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  29. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  30. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  31. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  32. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  33. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  34. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  35. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  36. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  37. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  38. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  39. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  40. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  41. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  42. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  43. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  44. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  45. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  46. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  47. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  48. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  49. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  50. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
  51. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: FPNV POSITIONING MATRIX
  1. Certara, L.P.
  2. Clinigen Group PLC
  3. Cognizant Technology Solutions Corp.
  4. HealthiVibe, LLC
  5. IBM Corporation
  6. ICON PLC
  7. IQVIA
  8. Mercy Technology Services
  9. Oracle Corporation
  10. PAREXEL International Corporation
  11. Pharmaceutical Product Development, LLC
  12. SAS Institute, Inc.
  13. Sciformix Corporation
  14. Syneos Health
  15. Turacoz